ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
01 Mayo 2024 - 3:30PM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that Nikhil Lalwani, Chief Executive Officer, and Stephen
Carey, Chief Financial Officer, will participate at two upcoming
healthcare conferences in New York City as follows:
Capital One
1st Annual Biotech/Biopharma
Disruptors Event |
|
|
Date: |
Tuesday, May 14, 2024 |
|
|
Time: |
12:15pm ET |
|
|
To schedule a 1x1
meeting with management, please contact
kristen.patrick@capitalone.com |
|
|
H.C.
Wainwright 2nd Annual BioConnect
Conference at NASDAQ |
|
|
Date: |
Monday, May 20, 2024 |
|
|
Time: |
9:00am ET |
|
|
Webcast: |
Click Here |
|
|
To schedule a 1x1
meeting with management, please contact meetings@hcwco.com. |
The live and archived webcast will be accessible from the
Company’s website at www.anipharmaceuticals.com, under the
Investors section under Events and Presentations. The replay of the
webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high-quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. The Company is focused on delivering
sustainable growth by scaling up its Rare Disease business through
its lead asset Purified Cortrophin® Gel, strengthening its Generics
business with enhanced research and development capabilities,
leveraging its U.S. based manufacturing footprint, and delivering
innovation in Established Brands. For more information, please
visit our website www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson,
In-Site Communications, Inc.
T: 212-452-2793 E:
lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De May 2023 a May 2024